Risk, reassurance and routine: a qualitative study of narrative understandings of the potential for HIV self-testing among men who have sex with men in England. by Witzel, T Charles et al.
Witzel, TC; Weatherburn, P; Rodger, AJ; Bourne, AH; Burns, FM
(2017) Risk, reassurance and routine: a qualitative study of narrative
understandings of the potential for HIV self-testing among men who
have sex with men in England. BMC Public Health, 17 (1). p. 491.
ISSN 1471-2458 DOI: 10.1186/s12889-017-4370-0
Downloaded from: http://researchonline.lshtm.ac.uk/3937872/
DOI: 10.1186/s12889-017-4370-0
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE Open Access
Risk, reassurance and routine: a qualitative
study of narrative understandings of the
potential for HIV self-testing among men
who have sex with men in England
T. Charles Witzel1*, Peter Weatherburn1, Alison J. Rodger2, Adam H. Bourne1 and Fiona M. Burns2
Abstract
Background: HIV testing has seen a rapid evolution over the last decade with multiple modalities now in use
globally. In recent years HIV self-testing (HIVST) has been legalised in the UK paving the way for further expansion
of testing. Interventions are delivered in particular social contexts which shape uptake. It is therefore important to
understand how novel interventions are likely to be received by their intended users. This study aims to understand
how HIVST compliments existing testing strategies considered or adopted by men who have sex with men (MSM).
We do this by analysing normative discourses surrounding HIV testing and their perceptions of HIVST’s potential
future roles.
Methods: Six focus group discussions (FGDs) were conducted with 47 MSM in London, Manchester and Plymouth.
One focus group included only MSM who reported higher risk behaviours and one with those who had never
tested for HIV. Data were analysed through a thematic framework analysis.
Results: Three main narratives for testing for HIV were identified: (i) testing in response to a specific risk event;
(ii) as reassurance when there was a small amount of doubt or anxiety related to HIV; and (iii) in response to social
norms perpetuated through peers, HIV community groups and the medical establishment to test regularly for HIV.
HIVST had limited utility for men when testing in response to specific risk events except in the case of significant
structural barriers to other testing opportunities. HIVST was considered to have utility when seeking reassurance,
and was thought to be very useful when testing to satisfy the needs and expectations of others around regular
testing. There was some ambivalence about the incursion of a clinical intervention into the home.
Conclusions: HIVST following risk events will likely be limited to those for whom existing service provision is
insufficient to meet immediate needs based on structural or personal barriers to testing. Obligations of biological
citizenship are central to MSM’s understanding of the utility of HIVST. In the context of discourses of biocitizenship,
men perceive HIVST to have dual roles: firstly as a tool to manage (mild) anxiety around one’s HIV status based on
an acknowledgment of HIV vulnerability arising from being homosexually active. Secondly, HIVST is useful in
complying with social norms and meeting the perceived demands of biomedicine.
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Background
HIV testing is essential for the diagnosis and treatment of
HIV, and alongside widely available antiretroviral therapy
(ART) has facilitated an enormous decrease in HIV re-
lated morbidity and mortality. The first HIV antibody test
became available in 1985 [1], and for many years testing
was only accessible in clinical settings with significant em-
phasis placed on pre and post-test counselling by trained
healthcare workers. Throughout the 1980s and most of
the 1990s, in the United Kingdom HIV testing was
primarily used as a diagnostic tool and was not actively
promoted in the name of HIV prevention, which in com-
bination with lack of any effective treatment resulted in
comparatively low rates of uptake [1].
As understanding of the public health benefits of redu-
cing undiagnosed infection and, latterly, treatment as
prevention (TasP) grew [2–7], testing underwent signifi-
cant expansion. Policy change and the introduction of
low-cost rapid diagnostic tests (RDTs) facilitated this. In
2008 the British HIV Association (BHIVA) UK guide-
lines recommended annual HIV testing among men who
have sex with men (MSM) (or more frequently if at
increased risk) [8]. More recently, the 2014 British
Association for Sexual Health and HIV (BASHH) guide-
lines call for annual testing for MSM with 3-monthly
HIV testing for MSM following ‘unprotected’ sexual
contact (oral, genital or anal) with a new partner, follow-
ing an STI diagnosis, or the use of drugs which might be
a marker of risk behaviour [9]. RDTs meant testing
could now be delivered in a variety of settings not just
by clinical staff but also community health workers and
volunteers.
Testing interventions in the UK proliferated both
within and beyond clinical settings [10–14]. More re-
cently testing has moved into the domestic and private
spheres with the introduction of self-administered test-
ing methods such as HIV self-sampling (HIVSS) and
HIV self-testing (HIVST) [15, 16]. Individuals utilising
HIVSS collect the sample themselves, then post it to a
laboratory who processes it and returns a result. With
HIVST, individuals perform an RDT themselves and in-
terpret their own result. Currently available HIVSTs in
the UK are all 2nd generation, meaning that the period
between infection and a reactive result is around
12 weeks [17]. HIVST is simply the latest technological
innovation, which further increases the volume and var-
iety of ways in it is feasible to establish one’s current
HIV status. HIVSS is provided by the statutory and vol-
untary sectors across much of England, while HIVST is
currently only available commercially (not withstanding
sporadic public provision through pilot and demonstra-
tion projects).
Public health discourses around testing have also
shifted, and increasing the frequency with which MSM
test has become a dominant focus of HIV prevention ef-
forts. Indeed, recent campaigns (see Fig. 1 for an example)
for groups most affected by HIV in the UK have moved
on from focusing primarily on condom use to an almost
exclusive focus on the promotion of HIV testing [18, 19].
While expansion of the volume and variety of testing
opportunities has increased rates of HIV testing and re-
duced undiagnosed infections particularly in MSM [20],
about half of MSM continue to test less frequently than
advised in the BASHH and BHIVA guidelines and about
25% have not tested at all [21–24]. Six monthly testing
uptake estimates for MSM at higher risk vary between
27 and 60% depending on the study [21, 22]. Meanwhile
social norms emphasising frequent HIV testing among
MSM have become pervasive, with conceptualisation of
personal responsibility increasingly emphasising testing,
rather than condom use alone [19, 25]. HIV testing is
also the gateway to biomedical HIV prevention interven-
tions, including pre (PrEP) and post-exposure prophy-
laxis (PEP) as well as TasP [4, 26, 27].
HIV testing discourses are both varied and dynamic.
Commonly understood narratives around patient initi-
ated HIV testing include: testing in response to a risk
event; because of symptoms which may be indicative of
Fig. 1 HIV testing campaign in situ in London (Do it London, 2016)
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infection; out of a feeling of responsibility to oneself or
partners; or as part of health-seeking routines [25, 28].
Testing for HIV is embedded in particular cultural con-
texts and frameworks that can link HIV infection with
deviance, promiscuity, shame and notions of immorality,
making testing decisions particularly complex [29].
As HIV testing services continue to expand, HIVST
may be utilised by commissioners as a low cost alternative,
triaging patients unlikely to have HIV infection away from
facility based testing. HIVST is also thought useful for in-
creasing the frequency of testing for those who are most
at risk and test insufficiently often [15, 27, 28]. It is crucial
to understand, however, what role HIVST will play along-
side the diverse array of HIV testing interventions
available to and targeted at MSM in the UK. Further, HIV
testing is often promoted and discussed by MSM in offline
and online environments [18]. As interventions are
delivered within particular social contexts, understanding
normative discourses through narrative analysis in the
groups which they target is an important component in
understanding intervention potential upon implementa-
tion. This is particularly true in light of strong critiques of
the responsibilisation of public health often put forward
by sociologists concerned about the impact of the conver-
gence of identity and the lived embodiment of a risk state
among the ‘most’ at risk in society [29–31], a process if
often referred to as biomedicalisation.
This study therefore aims to understand how HIVST
compliments existing testing strategies considered or
adopted by MSM. We do this by analysing MSM’s narra-
tives surrounding HIV testing and their accounts of
HIVST’s potential future roles. As a study grounded in
implementation science, a field which seeks to translate
research evidence into policy and practice [32], our re-
sults will be of interest to policy makers and commis-
sioners who seek to understand the potential role
HIVST will have in the sexual lives of MSM in high in-
come settings. In particular, this manuscript focuses on
the implications of these narratives for feasibility, poten-
tial intervention reach and equity concerns.
Methods
Full methods for this study are reported elsewhere [33].
Below we include an abridged version.
Study design
This qualitative descriptive study was conducted as part
of the formative phase of SELPHI, a randomised con-
trolled trial (RCT) taking place in England and Wales.
To inform intervention design, our qualitative research
sought to capture the perspectives of MSM in relation
to HIV testing generally and HIVST specifically. Focus
group discussions (FGDs) were utilised to situate the
perspectives of individual MSM in the context of group
mediated norms, such as those held within individuals’
social networks. This analysis was not planned when this
study was conceptualised, instead, the emerging narra-
tives proved to be useful for intervention design, thus
warranting further analysis.
Study sites and health service features
Fieldwork occurred in London, Plymouth and Manchester.
These cities were chosen as they have a variable prevalence
of HIV and differ in their population density of MSM
[20, 34]. They also vary substantially in the provision and
diversity of gay venues and HIV and other sexually transmit-
ted infection (STI) testing services. At the time of the study
Plymouth and the surrounding counties of Devon and
Cornwall were the only location in England where HIVST
was available at no charge through an NHS pilot initiative.
Study participants & recruitment
MSM, including trans MSM, who were over the age of
18 and did not have diagnosed HIV were eligible for in-
clusion in this study.
Acknowledging differing patterns of and perspectives to-
wards testing across sub-groups, purposive quota sampling
was used to ensure diversity regarding age, ethnicity, sexual
orientation and past HIV testing experience including loca-
tions of previous HIV tests. In particular, we sought to in-
clude more men outside the ages of 26–39, as these are less
likely to test in line with BHIVA guidelines [21, 24]. Further,
we over-sampled men from ethnic minority backgrounds
theorising that their barriers and motivators to testing may
be different to men of white ethnicity [21]. We also focused
on including larger numbers of participants who had uti-
lised self-administered testing or sampling methods includ-
ing HIVSS and HIVST. See Table 1 for demographic and
health service use details of focus group participants.
Sampling proceeded iteratively, and as study recruit-
ment unfolded, we made efforts to recruit those who
had never tested for HIV and men at potentially higher
risk of HIV transmission (defined as 2 or more condom-
less anal intercourse (CAI) partners in the preceding
3 months). This was partly because data saturation was
reached after only four general groups, and also on the
premise that these individuals might have greater utility
for HIVST given testing guidelines urging quarterly
testing for MSM with multiple condomless sex partners
[8, 9], and the potential for HIVST to provide a gateway
to testing for men who have never previously tested
[35]. The first four focus groups (two in London, one in
Plymouth and one in Manchester) were shaped by our
general purposive sampling quotas, with one additional
group conducted with men at higher risk, and one final
group exclusively for those never having tested for HIV.
Participants were recruited through gay, location-based
sexual networking applications as well as community-
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based organisations in the three cities. Men were directed
to webpages detailing the study. They were invited to
complete a short survey providing demographic details
and, if eligible, their contact details. Participants were then
selected and invited to groups based on our sampling
frame. Participants were compensated £40.
Data collection and analysis
FGDs were co-facilitated by the lead author and mem-
bers of Sigma Research.1 A topic guide was developed
collaboratively within the research team and refined after
the initial focus group. The topic guide covered HIV
testing behaviour, HIVST intervention specific details
and perceptions of HIVST in relation to other testing
opportunities. This analysis mainly focuses on the first
section exploring how HIVST fits into health seeking
frameworks. We began this section asking about the per-
ceived barriers and facilitators to HIVST before moving
on to hypothetical discussions about the likely situations
in which individuals perceived it more or less appropri-
ate to use HIVST. Finally, we asked about key influences
on testing decision making, including risk, personal
history and peer groups.
FGDs were transcribed verbatim. All authors famil-
iarised themselves with the transcripts and agreed a the-
matic coding framework through consensus following
the approach describe by Richie and Spencer [36]. This
approach was chosen to reduce inherent bias in data
analysis. This framework included higher-level codes
such as risk, reassurance, and norms; within which
nested sub-themes describing the most common
understandings expressed by participants. The data were
coded deductively initially, then the sub-themes were
coded inductively to derive more nuanced understand-
ings of testing narratives. This analysis was conducted
using QSR NVivo 10.
Ethical considerations
Ethical approval was granted by the London School of
Hygiene & Tropical Medicine observational research
ethics committee (reference 9893).
Reflexivity
This work is the product of a collaborative, multi-
institutional, interdisciplinary effort conducted in the
formative phase of the development of the SELPHI
RCT. As such the team holds diverse perspectives on
the potential role for health service and civil society in
HIV prevention in high incidence groups. All authors
believe that increasing the volume and variety of ways in
which MSM can be empowered to learn their HIV status
is productive so long as interventions are useful to MSM
and meet their aspirations related to their sexual health.
Results
Our analysis identified three main narratives surround-
ing potential reasons to test for HIV: (i) testing in re-
sponse to a specific risk event; (ii) as reassurance when
there was a small amount of doubt or anxiety related to
HIV; and (iii) in response to social norms perpetuated
through peers, HIV community groups and the medical
establishment to test regularly for HIV. During FGDs we
did not ask our participants to describe their motivations
or the anticipated motivations of others to seek HIV
testing. Rather these narratives were volunteered within
groups and explored further when appropriate. Here we
describe each narrative about HIV testing generally in
turn and then examine the utility of HIVST as a testing
technology in response to each of these motivations.
Testing as a response to risk
The most cited reason to test for HIV was in response
to a risk event, usually CAI outside a monogamous sero-
concordant relationship. There was a perception that for
many men, this was the only rationale for testing for
HIV and without such a driver, individuals would not
seek testing. The importance of testing for HIV follow-
ing a risk event was universally acknowledged among
our sample.
For those who had never tested, the most common
narrative for not having done so was that they had used
condoms consistently throughout their sexual careers
and did not feel themselves to be at risk for HIV, and
therefore felt HIV testing was not relevant for them.
Table 1 Sample characteristics
Demographic characteristic MSM recruited
n = 47
Age group (range 18–64) 18–25 years
26–39 years
40+
9
21
17
Ethnicity Black
Asian
White
Other/Mixed
4
6
37
0
Sexual orientation Gay
Bisexual
Other
38
5
4
Recency of HIV testing Never tested
Tested over
12 months ago
Tested in
preceding 12 months
8
9
30
Past use of HIV testing locations
(multiple answers allowed)
Genitourinary
medicine clinic
General practice
Community based
testing
Self-sampling
Self-testing
30
6
6
11
4
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Well, I haven’t had an HIV test and I’ve got a partner
for 40 years now, but I do have other people as well,
but I always have safe sex. Maybe because they
have safe sex, they don’t think they have to test.
(62-year-old gay man, never tested group).
HIVST was not perceived to be useful by the majority
when seeking a test in response to a risk event or in the
context of ongoing sexual risk. This was partly due to
concerns raised by participants about longer window pe-
riods (reported in Witzel et al. [33]) and partly because
of the lack of individual support in HIVST interventions.
Many felt dislocation from clinical care and staff meant
they would not want to self-test if they thought there
was a realistic possibility that the result could be posi-
tive. Rather, in these narratives, support from doctors,
nurses and health advisors was central to motivations to
seek care.
[…] this sounds really stupid, but for me I’d probably
test on a self-testing thing and I'd probably be alright,
but I think if I knew something was… I'd go to the
doctor, which doesn’t make sense but it’s just.... yes, like
if I did something really crazy and I thought “Oh damn
that was bad,” the next day I probably would go to the
doctor, where generally [not testing in response to risk]
a self-test would be okay and that’s me being honest.
(46-year-old gay man, tested last 3 months, London).
For some, this was to do with the desirability of having
a more complete package of care including other STI
tests which were of some (although lesser) concern.
HIVST was presented as interrupting care in this con-
text, and providing it to people following a risk event
could be seen as contrary to public health objectives. For
these men, it was not just the HIV test that provided
comfort, it was also the care and support surrounding
testing services and provision of information and advice
around sexual health. This was particularly pronounced
among the men in the higher risk group.
Probably I would still go to the clinic, because as
[name redacted] said there’s the other stuff that it
doesn’t actually test for and it’s specifically looking for
one virus or antibody and it’s not looking for signs of
syphilis or gonorrhoea or NSU or anything like that, so
it would still be the same for me. I go to the doctor
every 3 months, 4 months. (31-year-old gay man,
tested in last 12 months, higher risk group, London).
The exception identified by men where HIVST was
useful in response to risk was where significant struc-
tural barriers to accessing testing existed and the mount-
ing stress made testing immediately crucial.
I think for me personally it would be more if I'd done
something and I was concerned and I wanted to know
quickly particularly if I tried to get an appointment at
the local clinic and I had to wait a week or two to get
a slot because they're quite busy but if I wanted to
know really quickly then I'd prefer to get a test
that way (33-year-old gay man, tested in last
3 months, London).
HIV testing as reassurance
Testing to gain reassurance of ones continuing HIV
negative status was a common theme across our groups
shaped by our general purposive sampling strategy as
well as the higher risk group. While testing in response
to risk was usually a response to a specific trigger event,
testing as reassurance responded to recognition of an
ongoing higher risk of HIV in the gay community. This
need for reassurance about continued seronegativity was
constantly reinforced by interaction with peers, with bio-
medicine and health promotion services. This was de-
scribed in all FGDs, except for the group for those who
had never tested.
For many men, being homosexually active brought a
requirement to engage with the process of surveillance
of one’s HIV status. Social contacts were key in provid-
ing motivation and support for testing. Understanding
and appreciation of belonging to a risk group was part
of developing norms surrounding HIV testing, a dis-
tinctly social process which had a psychological impact.
None of my straight friends ever get tested, I don’t
think any of my female friends would know where to
go to get tested at all and with my gay friends we’d
text each other, and say: “It’s negative, everything is
clear” or: “I’ve got gonorrhoea. Gutted. Need to
get an injection in my bum.” Yeah, we talk about it.
(26-year-old gay man, tested in last 12 months,
higher risk group, London).
While individuals were often very confident of a
negative result when testing, low levels of background
anxiety surrounding HIV were strong motivators to test
regularly. Among individuals who tested very frequently,
ongoing reassurance was a key component of their
decision to seek HIV testing.
Interviewer: … but what’s the point in testing when
you are pretty sure you're negative?
Participant: I think it just reassures you even if there’s
a small degree of doubt, there’s a very very low chance
but there’s still a chance and actually it’s quite
affirming - it’s nice to have that reassurance.
(36-year-old gay man, tested in last 3 months, London).
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Risk of HIV in these narratives is viewed as a constant,
and HIV testing is useful in managing and monitoring
one’s own risk and providing reassurance.
HIVST was perceived by many as useful to reassure
oneself of a negative HIV status. This was particularly
true for those who described a growing anxiety between
tests despite the absence of a specific high-risk event.
Self-testing for these men offered the opportunity to
‘top-up’ between other tests, and in the context of seek-
ing reassurance from a self-test, the lack of support was
perceived to be far less problematic.
I'm conflicted now, I think I think I came here feeling
like I need comfort and I still feel like that but I also
wonder if it was just small multi-pack cheap free
casual testing… I wonder if that would be a nice thing
for me actually because it would remove any of the
building of the worrying about going to this place to
get it done … (29-year-old queer man, tested in last 12
months, higher risk group, London).
In terms of accuracy, HIVST was usually understood
as a sub-optimal technology with longer window periods
and less reliability when compared to point of care or la-
boratory testing available in other settings. For this rea-
son, HIVST was sometimes seen as a gateway to more
frequent testing for those who had a degree of anxiety
and some participants assumed individuals would seek a
confirmatory test whatever the result of the self-test.
Self-testing would be a brilliant thing because, yeah it’s
a bit like a pregnancy test. It might be wrong but it
then might give people that kind of push to maybe go
and then get tested again just reassure themselves…
(26-year-old gay man, tested in last 12 months,
Manchester).
HIV testing as routine – norms, peer groups and
biomedicine
HIV testing was strongly viewed as normative behaviour
by the majority of MSM in our groups, including those
who had never previously tested. The norm was suffi-
ciently pervasive that in our general FGDs, men who
had never tested struggled with disclosing this during
the FGD and most did not. In our group for men who
had never tested these disclosures remained difficult,
with some participants choosing not to discuss their un-
tested status although all members knew they were in a
group of MSM, none of which had ever tested for HIV.
Individuals identified key sources of influence as crucial
to developing social norms relating to HIV testing and the
frequency at which it should be done. Men cited friends
and peers as the principal information source around test-
ing methods, opportunities and novel interventions.
Health promotion practitioners and individuals working
in clinical services were also important in prompting
men to test, to repeat testing frequently and in
highlighting specific services. The gay media and the
commercial scene were also vital in the dissemination
of testing promotion messages, particularly in major
metropolitan areas.
Especially since I moved to Manchester, coming from
[city in Scotland] it’s a bit, the gay scene is a lot
smaller and its… I hadn't noticed any advertisement
and measures about it when I was there and as soon
as I got here it was all about. Everywhere "Test, Test,
Test, Test, Test" everywhere. And I think it has been
very very easy to get, to get done here and I have been
here 3 years and I think I have been tested three or
four times because its constantly everywhere like. So I
would say it’s quite positively done here to be honest.
(40-year-old gay man, tested in the last 12 months,
Manchester).
While there was an acknowledgement that not all were
testing as frequently as might be considered ideal, it was
clear that men valued regular testing and saw it as a
normative behaviour for all homosexually active gay and
bisexual men. Themes of responsibility were particularly
pervasive in discourses about regular testing, even
among those who were unclear what the ‘ideal’ fre-
quency was. These obligations were sometimes viewed
with ambivalence, particularly given perceptions about a
lack of consistency in messages about how frequently
they should test. However, the pervasive norm for regu-
lar testing was largely uncontested and widely advocated
and accepted as a part of being a ‘good gay man’.
One of the most common assumptions about HIVST
was that it was exceptionally useful for meeting the
expectations of peers (and biomedicine) surrounding
routine HIV testing. Pervasive norms about frequently
testing for HIV meant some participants felt that the
requirement to test placed too high a burden on their
time. For these men, HIVST was a way to meet social
and biomedical expectations while minimising the
opportunity cost to themselves.
Because you’re supposed to test…I think in theory, it
was meant to test – well, every 3 or 6 months, or every
new sexual partner. So in theory HIV self-testing, I
don’t think most people really use it for that [following
risk]. But then obviously in practice it’s different,
because a lot of people will just test if there’s a reason
to. So I guess if you’re testing as often as you should be,
then HIV self-testing perhaps will be useful to you, but
I don’t know about the other way. (42-year-old gay
man, tested in last 12 months, Plymouth).
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Self-testing was not always acceptable to men despite
strong social norms around HIV testing. Instead, for
men who were ambivalent or opposed, HIVST brought a
clinical intervention into the home, clashing with other
norms about what is appropriate in the domestic sphere.
[...]I would find it very difficult to envisage a situation
in which I sat at home at my dining table with my cat
looking at me with adoration whilst I identified my
HIV status by sticking something here and then
skewering my finger and then squeezing something in
and looking at some colour chart. (51-year-old gay
man, never tested group, London).
Discussion
In our focus group based study involving 47 MSM we
found three main narratives surrounding motivations to
test for HIV: i) in response to risk events, ii) as reassur-
ance, and iii) testing to satisfy social and medical norms.
HIVST had limited utility for men when testing in
response to specific risk events except in the case of
significant structural barriers. However, HIVST was con-
sidered to have utility when seeking reassurance, and
was thought useful when testing to satisfy the needs and
expectations of others around regular testing. There was
some ambivalence about the incursion of a clinical inter-
vention into the home. While health care professionals see
HIV testing as a gateway to prevention strategies such as
PEP, PrEP and TasP; this discourse was largely absent
within FGDs perhaps indicating that these interventions
are envisioned to take place within clinical services thus
diminishing the potential of HIVST in these.
Based on the narratives we present, self-testing follow-
ing risk events will likely be limited to those for whom
existing service provision is insufficient to meet immedi-
ate needs based on structural or perhaps personal
barriers to testing. Analysis of these narratives suggest
that widespread adoption of HIVST in response to risk
events is unlikely. Rather, men who are testing out of
concern following CAI will likely continue accessing
clinic based services, partly because of the much valued
support from staff, partly because of the acknowledge-
ment of the importance of STI testing and because of
the longer window periods of current HIVSTs compared
to clinic based POCT. The provision of self-sampling/
testing kits for bacterial STIs alongside well developed
and easily accessible pathways for men to access con-
firmatory testing for HIV and other STIs may go some
way to countering this concern, potentially also provid-
ing a clear link between individuals who are self-testing
and clinical services. This is in contrast with recent Scot-
tish data which indicated that MSM were willing to use
HIVST following a risk event, although which also re-
ports similar concerns around support [37].
Early adopters of new prevention technologies are
likely to have distinct motivations for accessing interven-
tions, usually reflecting an unmet felt need [38]. These
narratives are likely to be more indicative of how middle
and late adopters will perceive the utility and potential
of HIVST upon roll-out. It is essential to understand
these because they will shape initial reception, as the
potential of an intervention is understood primarily in
specific cultural spaces rather than through individual
clinical or health promotion interactions. These motiva-
tions will also likely change over time as MSM experi-
ence HIVST and incorporate the new opportunities it
affords into their health seeking frameworks.
Obligations of citizenship are central to MSM’s under-
standing of the utility of HIVST. Under notions of
biological citizenship individuals are expected to take an
active role in their health, including managing and moni-
toring risk. Good citizenship is demonstrated by MSM
through complying with the testing behaviours which are
expected of them. In doing so individuals organise around
biomedical categorisations and develop programmes of
self-care in collaboration with experts. Responsibility is
demonstrated through these regimes, and compliance
with these are central to belonging within these groups
[31, 39]. This process has contributed to a reframing of
biological or behavioural vulnerability into a socially lived
health state similar to disease [30, 39]. This is particularly
true for those deemed ‘most’ at risk by epidemiology and
the allied public health sciences [29].
Testing imperatives disseminated through varied pub-
lic health actors have led to increasing uncertainty
amongst MSM about the stability and durability of one’s
HIV status even in the absence of significant risk. Con-
sistent with an emerging body of literature [40–42], our
findings suggest that HIV risk is being conceptualised as
a health-state worthy of intervention in itself.
While notions of biological citizenship within this
group have historically focused on maintaining condom
use [43, 44], the emergent paradigm supplements (and
in some cases replaces) these messages with those re-
inforcing obligations of monitoring [45, 46]. This has
been constructed through the emphasis on testing regimes
disseminated by biopolitical actors such as policy organi-
sations, health promotion agencies and practitioners,
epidemiology, clinical staff and MSM themselves. While
much of the literature exploring this emerges from those
investigating PrEP and PEP use in individuals at high risk
of HIV infection [41, 42, 47], our research indicates that
this is a wider process which also includes HIV testing
norms and imperatives.
In the context of discourses of biological citizenship,
men perceive HIVST to have dual roles: firstly as a tool
to manage anxiety around one’s HIV status based on an
acknowledgment of HIV vulnerability arising from being
Witzel et al. BMC Public Health  (2017) 17:491 Page 7 of 10
homosexually active. Secondly, HIVST is useful in com-
plying with social norms and meeting the demands of
biomedicine. In this context HIVST is not necessarily
seen as problematic; the anxiety producing the need for
re-testing is very real and HIVST has potential to reduce
this. Similarly, the frequency with which MSM are
expected to test represents a significant burden on time.
HIVST allows men to meet these needs in a more
efficient way, both for themselves and potentially for
health services.
It is important to note that individuals interpret risk
subjectively through their own cultural and personal
frameworks which often are only partially based in bio-
medical understandings of the potential for HIV trans-
mission. While men do not currently appear to perceive
HIVST as particularly useful in testing following a spe-
cific risk event because of the relatively long window
period with currently available HIVST and lack of clin-
ical support, that does not necessarily mean that the
technology will not facilitate increased testing or reduce
the time from infection to diagnosis. These current dom-
inant narratives do however pose a challenge to the notion
that HIVST roll-out alone will reduce health inequalities
by cost-effectively preventing onward HIV transmission
by reaching significant numbers of high risk MSM who
might not otherwise be testing frequently enough.
Understanding the importance of testing as anxiety re-
duction and as routine indicates that developing HIVST
interventions integrated within existing services to for-
malise supplemental testing routines within a package of
care could be feasible and highly acceptable. These inter-
ventions could emphasise support through clinic visits
and remote portals, thus perhaps addressing some of the
well-being concerns generated by anxiety brought about
by biomedicalisation of risk. Such a package of care re-
mains unlikely to address equity concerns, however, as it
will by nature facilitate a more formalised and structured
clinical relationship between already engaged patients and
clinical staff. Indeed, based on the findings we present
here, penetration of HIVST in the medium term (when it
becomes widely available at no cost) will perhaps be partly
limited to those who are already engaged in sexual health
care, therefore not addressing health inequalities in the
way envisioned by public health practitioners.
Finally, our findings indicate that self-testing extends
the reach of risk governance from the clinic into the
home and will probably reduce the time interval
between tests for many MSM. Like many previous techno-
logical innovations, including RDTs and HIVSS, self-
testing reduces the time burden to know one’s HIV status,
an increasingly vital demonstration that an individual is a
‘good gay man’. Whether HIVST also reduces the time
between infection and diagnosis across the population of
gay men acquiring HIV remains to be seen.
Strengths and limitations
This manuscript presents the results of a formative quali-
tative study of narratives around HIV testing and HIVST
among MSM in the UK. While HIV testing motivations
within this group have been extensively studied and docu-
mented, this is the first UK research describing motiva-
tions for testing in the context of the possibility of HIVST.
This data will be useful when considered alongside emer-
ging evidence from Scotland which reports HIVST is
highly acceptable among MSM and stakeholders and
other data relating to this study [33, 37].
Our results should be interpreted with some caution.
Only four of our sample of 47 had previously used HIVST,
so our results largely relate to perceptions of a novel
intervention. To counter this concern we over-sampled
individuals who had accessed HIVSS, but there remain
key differences between these interventions, particularly
surrounding support and care pathways. Concerns around
support will therefore potentially be over-emphasised and
more research is needed to understand how these are
borne out when HIVST is more widely used.
Further, it warrants emphasising that this is an analysis
of narratives surrounding HIV testing motivations, and
that these therefore are reflective of normative under-
standings explored by our participants. While useful for
understanding HIVST intervention potential, it is also
likely that the diversity of the population of UK MSM
and their decision making will not be fully represented
in these accounts.
Conclusions
In conclusion, MSM in our study typically did not iden-
tify HIVST as a useful intervention when testing in re-
sponse to risk unless significant structural barriers to
testing existed. When testing to seek reassurance or in
response to the expectations of biomedicine around regu-
lar testing, HIVST was considered to have utility. There
was some ambivalence about the incursion of a clinical
intervention into the home.
Endnote
1Sigma Research is a research unit at the London
School of Hygiene and Tropical Medicine which focuses
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sexual health.
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